Literature DB >> 26372966

NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor.

Casey O'Connor1, Kate L White2, Nathalie Doncescu3, Tatiana Didenko4, Bryan L Roth5, Georges Czaplicki3, Raymond C Stevens6, Kurt Wüthrich7, Alain Milon8.   

Abstract

The structure of the dynorphin (1-13) peptide (dynorphin) bound to the human kappa opioid receptor (KOR) has been determined by liquid-state NMR spectroscopy. (1)H and (15)N chemical shift variations indicated that free and bound peptide is in fast exchange in solutions containing 1 mM dynorphin and 0.01 mM KOR. Radioligand binding indicated an intermediate-affinity interaction, with a Kd of ∼200 nM. Transferred nuclear Overhauser enhancement spectroscopy was used to determine the structure of bound dynorphin. The N-terminal opioid signature, YGGF, was observed to be flexibly disordered, the central part of the peptide from L5 to R9 to form a helical turn, and the C-terminal segment from P10 to K13 to be flexibly disordered in this intermediate-affinity bound state. Combining molecular modeling with NMR provided an initial framework for understanding multistep activation of a G protein-coupled receptor by its cognate peptide ligand.

Entities:  

Keywords:  15N relaxation; GPCR activation; ligand binding affinity; molecular dynamics simulations; transferred NOE

Mesh:

Substances:

Year:  2015        PMID: 26372966      PMCID: PMC4586840          DOI: 10.1073/pnas.1510117112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.

Authors:  Yi-Min Tao; Qing-Lin Li; Cong-Fen Zhang; Xue-Jun Xu; Jie Chen; Ya-Wen Ju; Zhi-Qiang Chi; Ya-Qiu Long; Jing-Gen Liu
Journal:  Eur J Pharmacol       Date:  2008-02-19       Impact factor: 4.432

2.  Chemotype-selective modes of action of κ-opioid receptor agonists.

Authors:  Eyal Vardy; Philip D Mosier; Kevin J Frankowski; Huixian Wu; Vsevolod Katritch; Richard B Westkaemper; Jeffrey Aubé; Raymond C Stevens; Bryan L Roth
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

3.  Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR.

Authors:  Jeffrey J Liu; Reto Horst; Vsevolod Katritch; Raymond C Stevens; Kurt Wüthrich
Journal:  Science       Date:  2012-01-19       Impact factor: 47.728

4.  Identification of novel functionally selective κ-opioid receptor scaffolds.

Authors:  Kate L White; Alex P Scopton; Marie-Laure Rives; Ruslan V Bikbulatov; Prabhakar R Polepally; Peter J Brown; Terrance Kenakin; Jonathan A Javitch; Jordan K Zjawiony; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2013-10-10       Impact factor: 4.436

5.  Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampus.

Authors:  C Chavkin; C Bakhit; E Weber; F E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

6.  Direct detection of neuropeptide dynorphin A binding to the second extracellular loop of the κ opioid receptor using a soluble protein scaffold.

Authors:  Johannes Björnerås; Martin Kurnik; Mikael Oliveberg; Astrid Gräslund; Lena Mäler; Jens Danielsson
Journal:  FEBS J       Date:  2014-02       Impact factor: 5.542

7.  Reduction-of-dimensionality kinetics at reaction-limited cell surface receptors.

Authors:  D Axelrod; M D Wang
Journal:  Biophys J       Date:  1994-03       Impact factor: 4.033

8.  The dynamic process of β(2)-adrenergic receptor activation.

Authors:  Rie Nygaard; Yaozhong Zou; Ron O Dror; Thomas J Mildorf; Daniel H Arlow; Aashish Manglik; Albert C Pan; Corey W Liu; Juan José Fung; Michael P Bokoch; Foon Sun Thian; Tong Sun Kobilka; David E Shaw; Luciano Mueller; R Scott Prosser; Brian K Kobilka
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

9.  Functional dynamics of deuterated β2 -adrenergic receptor in lipid bilayers revealed by NMR spectroscopy.

Authors:  Yutaka Kofuku; Takumi Ueda; Junya Okude; Yutaro Shiraishi; Keita Kondo; Takuya Mizumura; Shiho Suzuki; Ichio Shimada
Journal:  Angew Chem Int Ed Engl       Date:  2014-10-03       Impact factor: 15.336

10.  Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation.

Authors:  N A Farrow; R Muhandiram; A U Singer; S M Pascal; C M Kay; G Gish; S E Shoelson; T Pawson; J D Forman-Kay; L E Kay
Journal:  Biochemistry       Date:  1994-05-17       Impact factor: 3.162

View more
  33 in total

Review 1.  Host Peptidic Hormones Affecting Bacterial Biofilm Formation and Virulence.

Authors:  Olivier Lesouhaitier; Thomas Clamens; Thibaut Rosay; Florie Desriac; Mélissande Louis; Sophie Rodrigues; Andrei Gannesen; Vladimir K Plakunov; Emeline Bouffartigues; Ali Tahrioui; Alexis Bazire; Alain Dufour; Pierre Cornelis; Sylvie Chevalier; Marc G J Feuilloley
Journal:  J Innate Immun       Date:  2018-11-05       Impact factor: 7.349

2.  Mechanism and site of action of big dynorphin on ASIC1a.

Authors:  Christian B Borg; Nina Braun; Stephanie A Heusser; Yasmin Bay; Daniel Weis; Iacopo Galleano; Camilla Lund; Weihua Tian; Linda M Haugaard-Kedström; Eric P Bennett; Timothy Lynagh; Kristian Strømgaard; Jacob Andersen; Stephan A Pless
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-12       Impact factor: 11.205

3.  NMR as a tool to investigate the structure, dynamics and function of membrane proteins.

Authors:  Binyong Liang; Lukas K Tamm
Journal:  Nat Struct Mol Biol       Date:  2016-06-07       Impact factor: 15.369

Review 4.  How Ligands Illuminate GPCR Molecular Pharmacology.

Authors:  Daniel Wacker; Raymond C Stevens; Bryan L Roth
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

Review 5.  New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.

Authors:  Andrew B Kleist; Anthony E Getschman; Joshua J Ziarek; Amanda M Nevins; Pierre-Arnaud Gauthier; Andy Chevigné; Martyna Szpakowska; Brian F Volkman
Journal:  Biochem Pharmacol       Date:  2016-04-19       Impact factor: 5.858

Review 6.  GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures.

Authors:  Ichio Shimada; Takumi Ueda; Yutaka Kofuku; Matthew T Eddy; Kurt Wüthrich
Journal:  Nat Rev Drug Discov       Date:  2018-11-09       Impact factor: 84.694

7.  Opiates Modulate Noxious Chemical Nociception through a Complex Monoaminergic/Peptidergic Cascade.

Authors:  Holly Mills; Amanda Ortega; Wenjing Law; Vera Hapiak; Philip Summers; Tobias Clark; Richard Komuniecki
Journal:  J Neurosci       Date:  2016-05-18       Impact factor: 6.167

8.  Conformational Changes in Tyrosine 11 of Neurotensin Are Required to Activate the Neurotensin Receptor 1.

Authors:  Fabian Bumbak; Trayder Thomas; Billy J Noonan-Williams; Tasneem M Vaid; Fei Yan; Alice R Whitehead; Shoni Bruell; Martina Kocan; Xuan Tan; Margaret A Johnson; Ross A D Bathgate; David K Chalmers; Paul R Gooley; Daniel J Scott
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-29

Review 9.  Structural biology of human GPCR drugs and endogenous ligands - insights from NMR spectroscopy.

Authors:  Guillaume Ferré; Matthew T Eddy
Journal:  Methods       Date:  2020-09-08       Impact factor: 3.608

10.  A Dynamic Picture of the Early Events in Nociceptin Binding to the NOP Receptor by Metadynamics.

Authors:  Stefano Della Longa; Alessandro Arcovito
Journal:  Biophys J       Date:  2016-09-20       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.